Fundraising Fox

Duke Capital Partners2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Eloquent AIeloquentai.coin𝕏Sep 2025 · $7.4M

Eloquent AI builds an enterprise AI platform that automates customer operations and agent tasks for regulated industries like banking, insurance, and fintech.

AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US

Tugce Bulut(Founder)inAldo Lipani(Founder)in

Co-investorsHomebrewMetis VenturesRevo CapitalTranspose Platform ManagementValia VenturesY Combinator+5 more

Extellisextellis.comOct 2025

Extellis is developing satellite technology to deliver high-resolution (1 m) Earth imagery at industrial scale for remote monitoring applications.

Deep TechDefense TechHardwareSpace TechDurham, US

Jeffrey Ludwig(Executive Officer)Michael Boyarsky(Executive Officer, Director)

BoardJustin Wright-Eakes(Director)inDavid Smith(Director)in

Co-investorsFirst Star VenturesOval Park Capital

Neurophosneurophos.cominNov 2025

Neurophos develops photonic AI accelerator chips (the OPU) that use photonic tensor cores to deliver high compute throughput at low power draw, aiming to compress a full GPU rack into the size and power of a single GPU.

AI & Machine LearningDeep TechSemiconductorsAustin, US

Patrick Bowen(Executive Officer, Director)Hod Finkelstein(Executive Officer)Preston Woo(Executive Officer)

BoardChristopher Alliegro(Director)Nathan Kundtz(Director)

Co-investorsBeyond Earth VenturesBosch VenturesBuilder CapitalDnx VenturesRobert Bosch Venture CapitalSilicon Catalyst+4 more

Sprinter Healthsprinterhealth.cominApr 2025

Sprinter Health provides at-home healthcare services powered by technology to expand patient access to care and reimagine the patient experience at scale.

Digital HealthHealthtechMenlo Park, US

Max Cohen(Co-founder & CEO)inCameron Behar(Co-founder & CTO)in

BoardJulie Yoo(Director)inHolly Maloney(Director)in

Co-investorsAndreessen HorowitzGeneral CatalystSamsung NextAccel

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.